Anti-VEGF treatments have been saving the sight of thousands of people since 2006. In return, however, patients have been making clinical visits as often as monthly for injections. Not only is that a burden on their, and their doctors’, time, but it is very expensive and carries risks. To address the problem, new drug-delivery systems [Read More]
Category: Research and Developments
Study May Lead to More Accurate Long-Term Prediction of Wet AMD
Stanford University School of Medicine scientists have found a new way to forecast which patients with age-related macular degeneration (AMD) are likely to progress to the advanced wet form of the disease. Until now, there has been no effective way to to do this. The new method predicts whether a patient’s vision would, if untreated, probably [Read More]
Stem Cells Might Now Replace Photoreceptors
The media has been full of news about sight restoration from stem cells. In trials, stem cells are healing the retinal layer (retinal pigment epithelium) that supports the nerve cells (photoreceptors) responsible for seeing light. Scientists, however, have not yet been able to replace damaged photoreceptor cells in humans, but a recent study offers hope [Read More]
"Hubble Lens" May Be Next IOL For AMD
by Dan Roberts London Eye Hospital Pharma announced today that it has initiated U.S. discussions to gain clinical data for its iolAMD lens system. iolAMD is a novel intraocular lens (IOL) system designed to restore lost vision and provide an independent lifestyle for patients with dry AMD and related diseases. The technology behind the iolAMD lens [Read More]
Study Shows No Difference Between Tinted and Clear IOLS
by Dan Roberts For several years, eye doctors have been debating the value of tinted intraocular lenses (IOLs) in eyes that have undergone cataract surgery. Those in favor of them argue that they reduce the retina’s exposure to potentially hazardous ultraviolet and blue light. The main argument against them is that they cause a decrease [Read More]